Queensland life sciences
directory

Medicsen has invented a Needle- free Smartpatch for painless delivery of large drugs like insulin, heparin or antibodies using safe ultrasound waves. We have a great team of 16 professionals, a granted patent, a working prototype validated in vivo with 15 pigs and strong interest from the TOP pharma and medtech companies including funding and LOIs.

Melcare is a Life Science company with core competencies in thetherapeutic use of honey. Our products are designed to support and improve treatment outcomes in the areas of eye care, wound and skin care, nasal care and the symptoms of the common cold.

Merck offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services, and digital offerings help create solutions for people globally and a sustainable future for generations to come.

Michael Buck IP is an independent, boutique intellectual property firm, based in Brisbane Australia. We help creative, innovative and inventive people and businesses to protect, defend and commercialise their intellectual assets. Our clients range from local companies and individual inventors to start-ups, international corporations, universities and research organizations.

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.

Microbio is an Australian biotechnology startup that aims to revolutionise pathogen detection with our unique, specific, sensitive and fast pathogen identification test. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology.

Micromune Therapeutics is a startup aiming to develop a small molecule therapeutic for inflammatory bowel disease derived from the microbiome. This builds on research by Mater Research Institute-UQ Associate Professor Jakob Begun and UQ’s Institute for Molecular Bioscience’s Professor Rob Capon.

Midnight Health, a digital health platform to help patients access telehealth consultations, prescriptions, treatments, and other services.

MinterEllison provides legal and consulting services to a diverse client base across industries through offices in Australia and a global network of member firms and associated companies. In Australia, MinterEllison is one of the country's largest law firms.

Morrison Oriental is an Australian-based global business network that supports Australia's supply chain resilience and energy independence through innovation. Our diverse operations span over five countries/markets across the Asia Pacific Region.

information to follow

NeoRehab provides a clinically validated telehealth system for rehabilitation consultations. The eHAB® system allows clinicians like physiotherapists, audiologists, speech pathologists and occupational therapists to provide cost effective services to their patients, regardless of their location. The system was designed by experienced rehabilitation practitioners and offers a simple, intuitive solution for both practitioners and their clients.

Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is now a recognized world leader in the discovery and production of enzymes for molecular biology applications.

Northwest Healthcare Properties Australia is a leading company focused on owning, managing, and developing top-tier hospital, health, and life sciences properties in Australia and New Zealand. With approximately A$6.8 billion in assets under management, they are the largest healthcare real estate owner and developer in the region. Northwest boasts a portfolio of 73 properties with around 270 tenants. They also have a robust development pipeline of approximately A$3.1 billion, with 15 committed projects, 11 of which are currently under construction.

Founded in 2004 and publicly traded since 2010, Northwest (TSX: NWH.UN) is a global real estate investor and asset manager focused on properties and partnerships at the intersection of healthcare, knowledge, and research. We're a real estate investment trust with more than $10B of assets under management, owning and operating a portfolio of more than 230 high-quality properties across Canada, the United States, Brazil, Germany, the Netherlands, the United Kingdom, Australia, and New Zealand.

NuPlant has developed advanced robotic systems for plant tissue-culture. Our SmartClone Sirius and Gemini systems support dissections every three seconds; they unprecedently allow dynamic media change. Our Janus transplanter transfers plantlets to soil and re-assembles consumables for washing in our Neptune system for sustainable re-use. These systems flexibly provide tougher plantlets in shorter time at lower cost.

Nucleus Network's Brisbane facility, formerly known as Q-Pharm, is a dedicated clinical trial unit situated at the Royal Brisbane and Women's Hospital. As Australia's second-largest Phase 1 unit, it conducts clinical trials for companies and researchers involved in developing new, safer, and more effective medications. With over 15 years of reliable experience, Q-Pharm has successfully completed over 400 Early Phase studies and recruited over 15,000 participants. Specializing in early-phase (phases 1 and 2) clinical trials, Q-Pharm operates in a cutting-edge facility located in the Herston precinct at the Royal Brisbane and Women's Hospital in Brisbane, Australia.

OneVentures are one of Australia’s leading venture capital firms, with over $650 million in funds under management and are now looking for new opportunities in the healthcare and technology sectors. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets.

Orthodynamics uses world-first technology to enable orthopaedic surgeons to virtually plan highly personalised surgeries, providing them with 3D printed anatomical models and surgical guides to assist in the operating theatre.

Our Eco Bee’s provisionally-patented technology incorporates revolutionary beekeeping and agricultural eco-system inventions which seek to solve complex ecological, environmental and social problems to ensure: · Beekeepers are profitable and productive · Honey bees are flourishing · Food security is accessible · Agribusiness is sustainable To learn more, please contact Jen Wilks on 61 403 714 006 or via email jen@ourecoclean.com or visit our website.

PEMDx is a medical device company based in Brisbane Australia. A joint collaboration of medical doctors and engineers solving clinical health problems. Their world-first respiratory monitor helps health care staff conduct respiratory assessments. The bag can be fitted to any standard oxygen mask, and it inflates and deflates as a patient breathes.

PEP Health is a communications platform that provides a unique way for patients to monitor, manage and communicate their health journey with their clinical team. Patients use the same tools (clinical surveys, wearables, laboratory test results) their clinicians employ, to monitor and communicate their progress, symptoms and side effects providing their care team with a continuously updated health status snapshot.

PSC Biotech is a provider of life sciences essential services, ensuring the development, manufacturing, and distribution of medical and biotech products meet regulatory standards. The Australian team specializes in GMP Engineering, offering expertise in commissioning, qualification, and validation (CQV). They assist with validation project planning, documentation generation, execution, and summary reports. Additionally, PSC Biotech offers computer system validation (CSV) and technical writing support for operational readiness. Their focus is on maintaining compliance and delivering high-quality services in the life sciences industry.

Pandemic Advisory & Audit has developed the Sanitary Operational System. This is an innovative device that is scientifically tested, and proven, automated, safe in all spaces, food grade and eco-friendly dry vaporised fog sanitising and deep disinfecting device. The chemical composition has been approved by TGA and FDA as per SDS lodgements.

Parasym is a neurotechnology company focused on providing cutting edge, wearable bioelectric treatment solutions that improve quality of life through targeted modulation of the autonomic nervous system. Parasym's tech has exciting application in cardiovascular disease with RCT results showing improvement in atrial fibrillation burden and QoL in heart failure patients.

Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.

Pfizer is a pharmaceutical company dedicated to making breakthroughs that improve patients' lives and promote global health. They have a long history of innovation and a commitment to social responsibility. Pfizer works with healthcare professionals to gather real-world information for developing treatments, and they strive to make medicines accessible to underserved communities. The company engages in political partnerships in a legal and transparent manner and supports initiatives aligned with their medical and scientific strategies. They invest in research and development, and their executives and scientists lead the way in driving innovation.

PharmaSols is the longest established, best connected, privately-owned Clinical Research Organisation (CRO) in the Pacific region. They have international experience with large pharmaceutical, medical device and biotech organisations, with expertise across a wide variety of therapeutic areas.

Phaslo Global is an environmentally focussed climate tech business that operates in the cold chain logistics industry and specifically within the pathology, aviation and cold freight distribution industries. Phaslo offers environmentally friendly altrenatives to dry ice and polystyrene to temperature control by replacing with a Phase Change Formula.

Pizzey's Patent & Trade Mark Attorney is a specialist intellectual property firm, focusing on patents, trademarks, and designs, with expertise in establishing, maintaining, and enforcing intellectual property rights in Australia, New Zealand, and Singapore, known for its leadership in IP rights protection, driven by qualified attorneys dedicated to upholding the highest standards, offering quality, personalized, and responsive service, and operating as members of the IPH Limited group.

Protagonist Therapeutics is a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.

PEF's vision is to be a world leader in protein research services, technologies and training. PEF has a team of high-performing research specialists providing research capabilities and expertise on recombinant protein production.

Provectus Algae is an Australia-based biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.

Q-Sera Pty Ltd uses the coagulant properties of prothrombin activators to create proprietary blood collection tubes that rapidly produce high quality serum. Q-Sera has developed a gold standard serum tube, with a fast turn-around time that can be manufactured for universal implementation.

QHeart Medical was founded by a group of passionate cardiac device professionals focused on serving major unmeet clinical needs. We are currently commercialising a revolutionary low-risk low-cost heart therapy implant for highly unserved hypertensive heart failure and resistant hypertension.

QIMR Berghofer Medical Research Institute is a world- leading translational research institute where research develops from the laboratory bench to the patient’s bedside. With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes.

QUE Oncology is a clinical stage company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122, is focused on the treatment of hot flashes in breast cancer survivors undergoing endocrine therapy.

Queensland University of Technology (QUT) is a renowned Australian university that emphasizes a global perspective. With nearly 50,000 students, QUT offers real-world infrastructure, education, and graduate skills to empower the next generation of change-makers. Collaborating with various universities, institutions, and hospitals, QUT is dedicated to research excellence. Their research team is highly regarded for providing government, businesses, and organizations with top-notch research resources. QUT houses cutting-edge facilities and research groups focused on innovative research across various health disciplines. QUT is home to the Centre for Genomics and Personalised Health, contributing to advancements in personalized medicine.

Queensland Brain Institute (QBI), home to 250 researchers, all working to unlock the mysteries of the brain to generate new knowledge, understand learning and memory, develop new technologies to improve lives, and diagnose and treat brain disease and mental health. Support our exciting research.

Established in 2003, the Queensland Brain Institute is a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function.

QCIF (the Queensland Cyber Infrastructure Foundation) provides the high-performance services, infrastructure and support required to achieve excellence in computation and data-driven collaborative research and its application in industry. QCIF operates with its members and partners delivering services to research throughout Queensland and increasingly via Commonwealth programs to the nation.

The Queensland Eye Institute is one of the world’s finest centres for eye health, medical research, education and care. It is Queensland’s largest independent academic research institute devoted to eye related health and diseases.

Queensland is fast becoming Australia’s premier investment destination for biomedical and health industry projects. We have a dynamic and diverse economy supported by a pro-business government, sophisticated infrastructure and a skilled workforce.

QIC is a trusted investment manager and adviser providing risk adjusted returns for the clients we serve. As one of Australia’s leading institutional investment managers, we deliver alternative real asset solutions across infrastructure, real estate, private debt, private capital and natural capital in addition to a liquid market offering for our 125 Australian and global clients. We also act as the Queensland Government’s independent investment advisor, managing a fully-funded Defined Benefit scheme and the Queensland Future Fund both of which delivers on the State’s long-term investment objectives. We have US$65bn in assets under management (as at 31 March 2023) and are headquartered in Brisbane, Australia, with offices in Sydney, Melbourne, New York, San Francisco and London.

We are a global drug development accelerator with over 1,300 staff operating from state-of-the-art development, manufacturing and clinical testing facilities in the U.S. and U.K. We have over 30 years of experience and have worked on over 3,000 molecules across all stages of development.

Radium Capital is Australia’s market leader in advances of the R&D Tax Incentive refund. Since launching in 2017, we’ve helped hundreds of innovators build their businesses the strategic way.

Research Collective provides Development, implementation and management of research grant operations; Grants peer review and Change Management services in the health and medical research sector.

Resolian Bioanalytics is a leading global research laboratory providing services for the pharmaceutical, biotechnology, and medical device industries.

Sacco System embodies the fusion of international biotech expertise, catering to the food, nutraceutical, and pharmaceutical industries while supporting food culture and life, with its unique and collaborative network of Caglificio Clerici, Sacco, Centro Sperimentale del latte srl, and Kemikalia, offering a diverse range of innovative products such as starter cultures for food fermentation (especially dairy), nutritional supplements (probiotic cultures), and food enhancement instruments, preserving the distinct qualities and production capabilities of each entity.

Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.

Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.

Smilio.ai is a computer vision AI-powered platform that connects patients with dental providers to facilitate virtual consultations, digital oral health check-ups, cosmetic consultations, orthodontic assessments, and treatment monitoring.

We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.

Springfield City Group develops commercial, educational, healthcare, and residential real estate projects, with a vision of making Greater Springfield a sustainable regional city and services hub by 2030. BioPark Australia is to create a place where multiple biologic industries (Therapeutics, Vaccines, Med Tech, Diagnostics will co-locate and grow. Central to the BioPark will be its provision of the complete suite of necessary components and reagents for these industries. Future-proofing is built-in with staged expansion sites available to users.

Recognised for the experience and calibre of its people and high client service standards, Spruson & Ferguson is one of the largest and most trusted intellectual property (IP) service providers in the Asia Pacific region. Our life sciences team in Queensland provide strategic filing advice and services to a wide range of innovators, researchers, universities and businesses. Operating from 10 offices as a regional IP hub, clients can file in over 25 jurisdictions with a single instruction. Offices: Australia, Singapore, China (Beijing & Hong Kong), Indonesia, Malaysia, Philippines, Thailand. Spruson & Ferguson is a member of IPH Limited, an international IP services group comprising a network of member firms working throughout ten IP jurisdictions.

Strategic Engineering Australia is a consulting firm that specialises in process engineering, project management and strategic development. From setting up a manufacturing facility to developing and deploying new IT systems, ample experience enables Managing Director Shay Chalmers to intimately understand the entire manufacturing ecosystem.

Stryker R&D Lab officially opened in 2022. In partnership with Queensland Government, the University of Queensland, Queensland University of Technology, and Metro North Health, the Stryker lab will accelerate collaboration to deliver new medical technology innovations and collaboration in advanced manufacturing research.

Sycura Therapeutics is a startup aiming to evaluate a first-in-class brain penetrant small molecule as a preclinical candidate for amyotrophic lateral sclerosis (ALS). This builds on research at UniQuest’s small molecule drug discovery and development group, the Queensland Emory Drug Discovery Initiative (QEDDI) as well as research by Dr Richard Gordon from UQ Centre for Clinical Research.

Therapeutic Innovation Australia (TIA) provides a wide range of translational services. TIA works to lower the bar for researchers to access excellent translational research services in the fields of biologics, cell therapies, small molecules, preclinical testing and clinical trials.

Thermal Armour provides a cure for perioperative hypothermia, the most common serious adverse surgical event in the world.

Thermo Fisher Scientific is a company focused on enabling customers to make the world healthier, cleaner, and safer. They provide products and services in various areas, including genetic testing research, environmental goals, fertility restoration, and community support. The company emphasizes diversity and inclusion and strives to create an environment where differences are valued and everyone feels they belong. Thermo Fisher Scientific also highlights its corporate social responsibility and commitment to making a positive impact on society.

Thomson Geer is a large Australian corporate law firm, delivering services to a wide range of industry sectors and practice areas. Thomson Geer has offices in Sydney, Melbourne, Brisbane and Adelaide. By size, they are one of the 10 largest law firms in Australia.

TickerCardiology, a platform to improve diagnostic cardiology services using cloud-based technology.

Toowoomba and Surat Basin Enterprise (TSBE) is the go-to organisation linking business with opportunity to create sustainable growth and diversity for the region. TSBE is an independent, member-driven economic development organisation actively linking our business community to opportunities across the Toowoomba, Western Downs, Maranoa and surrounding areas.

Trade and Investment Queensland is the Queensland Government’s dedicated global business agency, helping Queensland exporters take their products to world markets and promoting Queensland as the perfect place for investment.

Initially qualified in the Medical Laboratory Sciences, Trevor has been involved in the Healthcare/Biotechnology sector for >30 years in various roles of laboratory, sales, marketing, operational and general management of both multinationals, Australian and self-owned companies.

The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.

The University of Southern Queensland (USQ) is a young, dynamic university. USQ has campuses in the regional centres of Toowoomba, Springfield and Ipswich. USQ is internationally recognised for delivering practical, world-class research that delivers high-impact solutions.

The UltraThera is a non-invasive, incisionless, and radiation-free medical device developed by researchers at The University of Queensland's Queensland Brain Institute. It uses low-frequency transcranial scanning ultrasound to treat brain diseases like Alzheimer's. By overcoming the blood-brain barrier, it enables a multi-modal therapeutic approach to address treatment limitations and facilitate the development of effective treatments.

UniQuest is Australia’s leading commercialisation entity, specialising in commercialising the intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in the top tier of technology transfer worldwide.

USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.

A young, fresh university driven by an unwavering belief that community and culture is just as important as a world-class education, delivered by world-class educators. We may not be the biggest university, but we’re growing fast, and doing big things. Like ground-breaking research, championing sustainability, producing gold-winning athletes and award-winning alumni. Our first campus, on the Sun

Uniseed is Australia’s longest running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and a leading Australian Superannuation Fund, UniSuper. These research organisations collectively spend $4 billion on research annually, making up over 40% of the total research spend in all research organisations in Australia.

The $70 million UQ Centre for Clinical Research (CCR) at the Royal Brisbane and Women's Hospital (RBWH) is focused on improving people's lives through patient-orientated research. Offer state-of-the-art facilities and bring together leading health professionals, clinicians and scientists from around the globe.

The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.

VALD Performance is a world leader in musculoskeletal assessment and rehabilitation technologies. VALD technologies are used by over 1,000 of the world’s most elite sports organisations, clinics, universities, hospitals and defence departments to measure human movement, performance and injury rehabilitation.

VFV is a fluid technology company providing fluid handling solutions in life sciences and design.

Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

Led by Director and Founder Dr. Patrick Silvey a specialist in Innovation Project design and scoping, VenturePro supports companies, government agencies, not-for-profits, and research organisations to become investment-ready. Dr. Silvey channels the talent and passion of VenturePro’s clients to turn discoveries and ideas into market-ready solutions or evidence-based policies for a better world. Over 18 years VenturePro has helped secure over $2.05 billion in funding for both short and long-term innovation projects and high-growth ventures.

ViceBio were founded to develop the patented Molecular Clamp technology invented at The University of Queensland, Australia and exclusively licensed to Vicebio by UniQuest, the commercialisation company of UQ. The Molecular Clamp technology stabilises viral glycoproteins in “prefusion” conformation, to deliver highly protective and ready-to-use fully liquid vaccines.

WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.

West is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies—working by their side to improve patient health.

Women in Technology (WiT) is one of Australia’s biggest communities that support women in across all fields of science and technology. As a not-for-profit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential. For more than two decades we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy.

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020.